Literature DB >> 11677267

Binding of nerve growth factor to its p75 receptor in stressed cells induces selective IkappaB-beta degradation and NF-kappaB nuclear translocation.

J M Cosgaya1, E M Shooter.   

Abstract

Nerve growth factor (NGF) regulates the activity of the transcription factor NF-kappaB (nuclear factor-kappaB) through its low affinity receptor, p75. In the present study we found that NGF binding to p75 induces nuclear translocation of p65 and increases NF-kappaB binding activity in a cell line overexpressing p75, but only after the cells have been subjected to a previous stress. Under physiological conditions, in the absence of stress, NGF is unable to alter p65 nuclear levels. Tumor necrosis factor-alpha (TNF-alpha) induces a down-regulation of IkappaB-alpha, -beta and -epsilon both in physiological and in stress, i.e. serum-free, conditions. In contrast, NGF only induces the specific degradation of IkappaB-beta after serum withdrawal, without affecting IkappaB-alpha or -epsilon either in the presence or in the absence of stress. IkappaB-beta consists of several isoforms, whose relative abundance is regulated by serum withdrawal. NGF does not target all the IkappaB-beta isoforms with the same potency, being more effective in reducing the levels of the isoforms up-regulated by serum withdrawal. TRAF-6 is expressed at the same level under both physiological and stress conditions. These results indicate that NGF is able to induce NF-kappaB nuclear translocation by a mechanism that involves specific IkappaB-beta degradation only after the cells have been subjected to a severe stress.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11677267     DOI: 10.1046/j.1471-4159.2001.00573.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

Review 1.  Cholinergic system during the progression of Alzheimer's disease: therapeutic implications.

Authors:  Elliott J Mufson; Scott E Counts; Sylvia E Perez; Stephen D Ginsberg
Journal:  Expert Rev Neurother       Date:  2008-11       Impact factor: 4.618

2.  Corticotropin-releasing hormone inhibits nuclear factor-kappaB pathway in human HaCaT keratinocytes.

Authors:  Blazej Zbytek; Lawrence M Pfeffer; Andrzej T Slominski
Journal:  J Invest Dermatol       Date:  2003-12       Impact factor: 8.551

3.  Ethanol induces upregulation of the nerve growth factor receptor CD271 in human melanoma cells via nuclear factor-κB activation.

Authors:  Germana Rappa; Fabio Anzanello; Aurelio Lorico
Journal:  Oncol Lett       Date:  2015-06-09       Impact factor: 2.967

4.  The p75NTR-mediated effect of nerve growth factor in L6C5 myogenic cells.

Authors:  Alessandra de Perini; Ivan Dimauro; Guglielmo Duranti; Cristina Fantini; Neri Mercatelli; Roberta Ceci; Luigi Di Luigi; Stefania Sabatini; Daniela Caporossi
Journal:  BMC Res Notes       Date:  2017-12-04

5.  LMO1 Plays an Oncogenic Role in Human Glioma Associated With NF-kB Pathway.

Authors:  Lei Gao; Jia Wu; Hai Wang; Yongyu Yang; Zongliao Zheng; Bowen Ni; Xiran Wang; Yuping Peng; Yaomin Li
Journal:  Front Oncol       Date:  2022-02-24       Impact factor: 6.244

Review 6.  The Role of Neurotrophin Signaling in Age-Related Cognitive Decline and Cognitive Diseases.

Authors:  Tadahiro Numakawa; Haruki Odaka
Journal:  Int J Mol Sci       Date:  2022-07-13       Impact factor: 6.208

7.  Increased nerve growth factor signaling in sensory neurons of early diabetic rats is corrected by electroacupuncture.

Authors:  Stefania Lucia Nori; Maria Luisa Rocco; Fulvio Florenzano; Maria Teresa Ciotti; Luigi Aloe; Luigi Manni
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-21       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.